Operating Company Healthcare

Alcami

Wilmington, North Carolina, United States

Alcami is a US-based contract development and manufacturing organization (CDMO) offering fully integrated lab services, drug product manufacturing (including sterile and oral solid manufacturing), and cGMP pharma storage and support services (e.g., environmental monitoring, calibration, and validation).

Focus Areas
Contract development and manufacturing (CDMO), Integrated lab services, Analytical development and testing
Website
alcami.com

Tracked deals

4

4 tracked deals across 2020-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Addon

2 addon · 2 buyout

Alcami Acquisition Volume by Year

Last 4 years

Acquisition volume by year Annual acquisition counts for the last 4 years for Alcami. 1 2020 1 2021 1 2024 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • April 21, 2026
    Buyer
    Alcami Corporation
    Target
    Tjoapack
    Seller
    Ampersand Capital Partners
    Location
    Netherlands
    Type
    Buyout

    Alcami Corporation entered into a definitive agreement to acquire Tjoapack, a global contract packaging organization serving pharmaceutical and biotechnology customers. The transaction expands Alcami’s footprint into Europe to create an end-to-end transatlantic CDMO platform with U.S.-Europe supply chain redundancy and added Qualified Person (QP) release services in Europe.

  • Buyer
    Alcami Corporation
    Target
    Pacific Pharmaceutical Services, Inc.
    Type
    Addon

    Alcami Corporation has completed the acquisition of Pacific Pharmaceutical Services, Inc. (PPS), a Reno-based cGMP pharmaceutical storage and clinical-support provider. The deal expands Alcami’s pharma storage and services footprint to the U.S. West Coast, enabling bicoastal coverage and enhanced support for pre-clinical and early clinical trial material management.

  • Buyer
    Alcami Corporation
    Target
    Masy Systems Inc. (Masy BioServices)
    Type
    Buyout

    Alcami Corporation, a pharmaceutical and biotech CDMO, completed its acquisition of Masy Systems Inc. (“Masy” or “Masy BioServices”), a provider of cGMP biostorage and pharma support services. The deal adds complementary capabilities and expands Alcami’s cGMP biostorage footprint; financial terms were not disclosed.

  • Buyer
    Alcami Corporation, Madison Dearborn Partners (funds affiliated)
    Target
    TriPharm Services
    Seller
    Ampersand Capital Partners
    Industry
    Pharmaceuticals
    Type
    Addon

    Alcami Corporation has acquired TriPharm Services, a new sterile fill‑finish manufacturing center near Research Triangle Park, North Carolina. Funds affiliated with Alcami majority owner Madison Dearborn Partners made an additional equity investment to support Alcami's growth plan, while Ampersand Capital Partners rolled a portion of its TriPharm ownership into Alcami.

Related Acquisition Pages

Selling a company? Get in front of buyers like Alcami

Turn tracked acquisition activity into an outreach-ready buyer list.